Whitfield Advises AmbioPharm on Merger with CordenPharma

Press Release   ·   29 May 2026

Overview

AmbioPharm and CordenPharma were to combine, according to the source announcement concerning two contract development and manufacturing businesses serving pharmaceutical customers.

Ownership background

The source identifies Carlyle as AmbioPharm's sponsor and Astorg as CordenPharma's owner. No merger valuation is disclosed in the announcement.

Manufacturing locations

AmbioPharm develops and produces peptide active ingredients, with facilities in North Augusta, South Carolina, and Shanghai.

Advisory participants

The listed corporate advisers include Laura Steinke, Gregory Scott and David Higgins. Sam Sherwood, Natasha Smith and Aman Nath are named for finance, with Adam Kool and Patrick Nolan for tax.